Study: Antibodies detected in 93% of those receiving both doses of Covishield vaccine

News Headline ::

Salt-tolerant crops ‘transform’ lives of farmers in Khulna Hamas studying new Israeli truce proposal as mediators seek to revive talks India to export 99,150 tonnes of onions to Bangladesh, 5 other countries 37m tonnes of debris in Gaza could take years to clear: UN Sammam Junaid’s Raat Kate Nirghum hits YouTube Mushfiq reaction coats DPL in further sorry paint China’s EV execs bullish on Western pressure at Beijing car show New York returns 30 pillaged relics to Cambodia and Indonesia Primary schools across Bangladesh to resume classes from Sunday Ethiopian Airlines, Air China to start operation in Bangladesh from May: CAAB

Home

Exclusive, National

Study: Antibodies detected in 93% of those receiving both doses of Covishield vaccine

Shawdesh Desk:

A study conducted by Department of Microbiology at Dhaka Medical College Hospital (DMCH) has found that the Oxford-AstraZeneca vaccine is developing antibodies in people who have received the jab.

The study found that 93% of people who received two doses of the vaccine developed antibodies within two weeks.

Antibody tests were conducted on 308 fully vaccinated individuals, who are doctors, nurses and other employees of Dhaka Medical College Hospital (DMCH).

The results were revealed in the lecture hall on the fourth floor of the new building of DMCH on Sunday.

Researchers said that they collected samples for antibody tests twice (after each dose of the vaccine). Four weeks after the first dose, they found antibodies among 41 percent recipients. Two weeks after the second dose, researchers found antibodies among 93 percent of the recipients.

The results, however, cannot be generalised for all who have been vaccinated, researchers said.